Allogenic UCMSCs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic UCMSCs, covering 2021-11-24 to 2021-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients [Phase 2, Phase 3]